Rheumatic Disease Research Core Center
风湿病研究核心中心
基本信息
- 批准号:6438550
- 负责人:
- 金额:$ 55.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-28 至 2006-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
OVERALL CENTER DESCRIPTION (provided by applicant):
We propose to establish a Rheumatic Diseases Research Core Center at the
University of Tennessee Health Sciences Center, Memphis. Research in rheumatic
diseases at this institution is characterized by a broad based,
multidisciplinary collaboration involving several Departments. We have
identified 26 scientists from 8 different Departments who share a common
interest in rheumatic disease pathogenesis that will form the research base for
this center. The theme of this proposal, "Extracellular matrix, Autoimmunity,
Cytokines and their Receptors in Rheumatic Diseases", represents their
interests and expertise. Individually, these investigators have been very
successful and it is the goal of this center to coordinate their efforts in
rheumatic disease research. The major objective of this proposal is to
encourage rheumatic disease research by enhancing the interaction, efficiency,
and productivity of the participating investigators; supporting novel research
directions; attracting new investigators to the field; encouraging
investigators in other disciplines to consider research in problems related to
rheumatic diseases; and facilitating research involvement by clinical faculty
and fellows. To support these objectives 3 cores are proposed. An
Administrative Core will provide overall coordination, external review, and
support for enrichment activities. A Molecular Resource Core will prepare
collagen, provide state of the art gene quantitation and discovery, and perform
HLA DQ and DR typing. An Animal Resources Core will provide well characterized
transgenic and knock out mice, and flow cytometric analysis of cells involved
in inflammation. Each of the cores will devote substantial effort to education
and training in the use of modem methods and approaches to rheumatic disease
research. We will establish a Pilot and Feasibility Program to encourage
creative endeavors. Included in this application are 3 projects representing
innovative proposals by new investigators. Recently, UTHSC designated
Connective Tissue Research as a Center of Excellence and committed substantial
support for new recruitment. This commitment will enhance our prospect for
success. Strong institutional support for rheumatology, superior physical
resources, and a favorable intellectual environment combine to make this an
opportune time to establish an RDCC at this institution.
中心总体描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW H KANG其他文献
ANDREW H KANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW H KANG', 18)}}的其他基金
Suppression of Collagen Induced Arthritis with Altered Peptide Ligands
用改变的肽配体抑制胶原诱导的关节炎
- 批准号:
7578745 - 财政年份:2009
- 资助金额:
$ 55.01万 - 项目类别:
Suppression of Collagen Induced Arthritis with Altered Peptide Ligands
用改变的肽配体抑制胶原诱导的关节炎
- 批准号:
7914434 - 财政年份:2009
- 资助金额:
$ 55.01万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 55.01万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 55.01万 - 项目类别:
Research Grant
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 55.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
Fellowship
The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis
炎症消退在类风湿关节炎发展中的作用和机制
- 批准号:
10733789 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis
微生物代谢物影响类风湿性关节炎对甲氨蝶呤的反应
- 批准号:
10578433 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别:
Fibroblast-mediated inflammatory resolution of rheumatoid arthritis
成纤维细胞介导的类风湿性关节炎炎症消退
- 批准号:
10604629 - 财政年份:2023
- 资助金额:
$ 55.01万 - 项目类别: